Visceral leishmaniasis (VL) is a severe infectious disease caused by a protozoan parasite: Leishmania donovani in East Africa and the Indian subcontinent and Leishmania infantum in Latin America ...

Findings from a new University of Maryland-led study could help doctors select more effective treatments earlier for patients ...

A discovery by Simona Stäger's team could help come up with a treatment for the most serious form of leishmaniasis. Leishmaniasis is a tropical disease affecting a growing number of people worldwide.

View Full Profile. Learn about our Editorial Policies. “Pentalinonsterol could represent the next generation of small-molecule-mediated immunotherapy for visceral leishmaniasis,” Elizabeth Sharlow, a ...

Looking for reliable medications to treat 'Leishmaniasis'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications.

Novartis’s (NVS) parasite-selective proteasome inhibitor with potent activity against kinetoplastid parasites was granted FDA orphan designation for treatment of leishmaniasis, according to a ...

Biomarkers have been identified that can predict the success of treatment for cutaneous leishmaniasis, a parasitic skin disease affecting nearly one million people annually.

COMSTECH, the Ministerial Standing Committee on Scientific and Technological Cooperation of the OIC, in collaboration with ...